Guztirako bisita-kopurua

Bisita-kopurua
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain290

Hilabeteko bisita-kopurua

November 2022December 2022
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain119
January 2023February 2023March 2023April 2023May 2023June 2023
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain98192416
July 2023August 2023September 2023
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain1542
January 2024February 2024March 2024April 2024May 2024June 2024
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain73324514
July 2024August 2024September 2024October 2024November 2024
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain3012482322

Fitxategiaren deskargak

Bisita-kopurua
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain.pdf43

Bisita gehien egiten diren herrialdeak

Bisita-kopurua
United States108
Spain86
China29
Singapore11
Belgium10
Australia8
Japan8
Argentina6
Germany4
Ireland4

Bisita gehien egiten diren hiriak

Bisita-kopurua
Vitoria-Gasteiz84
Boardman18
Shanghai17
Singapore8
Mumbai4
San Mateo4
Dublin3
Perth3
Ashburn2
Llandudno Junction2